Researchers at MIT have applied artificial intelligence to streamline the design of lipid nanoparticle (LNP) carriers for RNA vaccines and therapeutics. This work aims to overcome challenges in optimizing LNPs for delivery efficiency and specificity, potentially reshaping RNA drug development pipelines. The integration of AI promises to enhance therapeutic performance and speed up the creation of next-generation RNA-based medical interventions.